Peter Littler
Papers
1
Total Citations
30
H-Index
1
About
Peter Littler is a pioneering interventional oncologist whose work is redefining the landscape of non-invasive cancer therapy. His primary research focus centers on the clinical translation of histotripsy—a revolutionary, non-thermal focused ultrasound technique that mechanically liquefies targeted tissue. As the lead author of the landmark "#HOPE4LIVER Single-arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors" (2025), Dr. Littler has provided the first robust clinical evidence for this technology’s safety and efficacy in treating liver malignancies. This pivotal study, which has already garnered 30 citations, demonstrates his ability to shepherd novel therapeutic modalities from the engineering bench to the patient bedside. By showing that histotripsy can precisely ablate tumors without the heat-related damage of traditional thermal ablation, his work opens the door to safer, repeatable treatments for patients with limited options. Dr. Littler’s contributions are not merely technical; they represent a paradigm shift toward truly non-invasive, image-guided oncology. For students and researchers, his career exemplifies how rigorous clinical trial design can validate disruptive technologies, promising a future where cancer treatment is both more precise and less traumatic.
Research Focus
Key Achievements
Top Papers
- 1